KATHERINE MELLOW: Open Payments
NPI 1629791009 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 42 payments from 14 companies in 2025. Trend: 2023 $267 · 2024 $655 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $154 |
| Novo Nordisk Inc | 6 | $89 |
| Biogen, Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| Lundbeck LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $15 |
Products named: UBRELVY, Ozempic, ZURZUVAE, Auvelity, REXULTI, LINZESS, MOUNJARO, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
